WallStSmart

Atlassian Corp Plc (TEAM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Atlassian Corp Plc generates 2125% more annual revenue ($5.76B vs $258.90M). TEAM leads profitability with a -3.3% profit margin vs -15.5%. TEAM earns a higher WallStSmart Score of 52/100 (C-).

TEAM

Buy

52

out of 100

Grade: C-

Growth: 9.3Profit: 2.0Value: 7.7Quality: 4.0
Piotroski: 5/9Altman Z: 0.16

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TEAMUndervalued (+81.1%)

Margin of Safety

+81.1%

Fair Value

$459.97

Current Price

$68.59

$391.38 discount

UndervaluedFair: $459.97Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TEAM3 strengths · Avg: 8.7/10
EPS GrowthGrowth
172.2%10/10

Earnings expanding 172.2% YoY

PEG RatioValuation
0.638/10

Growing faster than its price suggests

Revenue GrowthGrowth
23.3%8/10

Revenue surging 23.3% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

TEAM4 concerns · Avg: 2.3/10
Price/BookValuation
11.5x4/10

Trading at 11.5x book value

Return on EquityProfitability
-13.5%2/10

ROE of -13.5% — below average capital efficiency

Altman Z-ScoreHealth
0.162/10

Distress zone — elevated risk

Profit MarginProfitability
-3.3%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : TEAM

The strongest argument for TEAM centers on EPS Growth, PEG Ratio, Revenue Growth. Revenue growth of 23.3% demonstrates continued momentum. PEG of 0.63 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : TEAM

The primary concerns for TEAM are Price/Book, Return on Equity, Altman Z-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

TEAM profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TEAM scores higher overall (52/100 vs 41/100) and 23.3% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Atlassian Corp Plc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Atlassian Corporation Plc designs, develops, licenses and maintains various software products worldwide. The company is headquartered in Sydney, Australia.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?